Non-genetic engineering of cells for drug delivery and cell-based therapy
Advanced Drug Delivery Reviews, ISSN: 0169-409X, Vol: 91, Page: 125-140
2015
- 209Citations
- 179Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations209
- Citation Indexes209
- 209
- CrossRef181
- Captures179
- Readers179
- 179
Review Description
Cell-based therapy is a promising modality to address many unmet medical needs. In addition to genetic engineering, material-based, biochemical, and physical science-based approaches have emerged as novel approaches to modify cells. Non-genetic engineering of cells has been applied in delivering therapeutics to tissues, homing of cells to the bone marrow or inflammatory tissues, cancer imaging, immunotherapy, and remotely controlling cellular functions. This new strategy has unique advantages in disease therapy and is complementary to existing gene-based cell engineering approaches. A better understanding of cellular systems and different engineering methods will allow us to better exploit engineered cells in biomedicine. Here, we review non-genetic cell engineering techniques and applications of engineered cells, discuss the pros and cons of different methods, and provide our perspectives on future research directions.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0169409X14003081; http://dx.doi.org/10.1016/j.addr.2014.12.003; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84940954525&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/25543006; https://linkinghub.elsevier.com/retrieve/pii/S0169409X14003081; https://dx.doi.org/10.1016/j.addr.2014.12.003
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know